Bonk, Inc. (BNKK)
NASDAQ: BNKK · Real-Time Price · USD
3.880
+0.070 (1.84%)
At close: Feb 27, 2026, 4:00 PM EST
3.776
-0.104 (-2.68%)
After-hours: Feb 27, 2026, 7:58 PM EST
Company Description
Bonk, Inc. provides over-the-counter products and consumer products in the United States.
The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content.
It also provides hair loss treatment, vitiligo solution, eczema cream, and sexual wellness products. It sells its products through direct customers, distributors, retailers, and e-commerce websites.
The company was formerly known as Safety Shot, Inc. and changed its name to Bonk, Inc. in October 2025.
Bonk, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Bonk, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Oct 30, 2020 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 8 |
| CEO | Jarrett Boon |
Contact Details
Address: 1061 East Indiantown Road, Suite 110 Jupiter, Florida 33477 United States | |
| Phone | 561 244 7100 |
| Website | bonkdat.com |
Stock Details
| Ticker Symbol | BNKK |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001760903 |
| CUSIP Number | 48208F105 |
| ISIN Number | US48208F3038 |
| Employer ID | 83-2455880 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Jarrett A. Boon | Chief Executive Officer and Director |
| David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., RSCC | Consultant |
| Markita L. Russell | Chief Financial Officer |
| Anthony Pedicelli | Director of Marketing |
| Dr. Andy Goren M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 3, 2026 | 424B3 | Prospectus |
| Jan 30, 2026 | EFFECT | Notice of Effectiveness |
| Jan 28, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 14, 2026 | 8-K | Current Report |
| Jan 5, 2026 | 8-K | Current Report |
| Dec 29, 2025 | 8-K | Current Report |
| Dec 12, 2025 | 8-K | Current Report |
| Dec 10, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Dec 8, 2025 | 8-K | Current Report |
| Dec 1, 2025 | DEF 14A | Other definitive proxy statements |